MorphoSys is open to discuss it proprietary clinical programs with interested parties on an ongoing basis and will proactively seek partners for later-stage development and commercialization.
Furthermore, MorphoSys is looking to in-license and collaborate on innovative target molecules or antibody product candidates. We are open to consider a broad range of deal structures including co-development arrangements.
